Development and validation of a rapid immunochromatographic assay for detection of Middle East respiratory syndrome coronavirus antigen in dromedary camels

Journal of Clinical Microbiology

Volumn 53, Issue 4, 2015, Pages 1178-1182

  Song, Daesub ^a   Ha, Gunwoo ^b   Serhan, Wissam ^c   Eltahir, Yassir ^c   Yusof, Mohammed ^c   Hashem, Farouq ^c   Elsayed, Elsaeid ^c   Marzoug, Bahaaeldin ^c   Abdelazim, Assem ^c   Al Muhairi, Salama ^c  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b BioNote Inc ^*  (South Korea)

^c Development sector   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOCAPSID PROTEIN; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; CORONAVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DROMEDARY; IMMUNOAFFINITY CHROMATOGRAPHY; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MEASUREMENT REPEATABILITY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOUSE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THERMOSTABILITY; VALIDATION PROCESS; ANIMAL; CAMEL; CORONAVIRUS INFECTIONS; ISOLATION AND PURIFICATION; NOSE CAVITY; PROCEDURES; VETERINARY; VIROLOGY;

CAMELIDAE; CAMELUS DROMEDARIUS; CORONAVIRUS;

ANIMALS; ANTIGENS, VIRAL; CAMELUS; CORONAVIRUS INFECTIONS; IMMUNOCHROMATOGRAPHY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NASAL CAVITY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIROLOGY;

EID: 84925264402     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03096-14     Document Type: Article

References (19)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367 1814-1820.: http://dx.doi.org/10.1056/NEJMoa1211721.
2. WHO. 2014. Middle East respiratory syndrome coronavirus (MERSCoV) - update (United Arab Emirates). World Health Organization, Geneva, Switzerland. http://www.who.int/csr/don/2014-07-14-mers2/en/.
3. Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, Madani TA. 2014. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 370:2499-2505. http://dx.doi.org/10.1056/NEJMoa1401505.
4. Corman V, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer T, Muth D, Muller M, Drexler J, Zambon M, Osterhaus A, Fouchier R, Drosten C. 2012. Detection of a novel human coronavirus by real-time reversetranscription polymerase chain reaction. Euro Surveill 17:pii=20285. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20285.
5. Corman VM, Muller MA, Costabel U, Timm J, Binger T, Meyer B, Kreher P, Lattwein E, Eschbach-Bludau M, Nitsche A, Bleicker T, Landt O, Schweiger B, Drexler JF, Osterhaus AD, Haagmans BL, Dittmer U, Bonin F, Wolff T, Drosten C. 2012. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 17:pii=20334. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20334.
6. Shirato K, Yano T, Senba S, Akachi S, Kobayashi T, Nishinaka T, Notomi T, Matsuyama S. 2014. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J 11:139. http://dx.doi.org/10.1186/1743-422X-11-139.
7. Abd El Wahed A, Patel P, Heidenreich D, Hufert FT, Weidmann M. 2013. Reverse transcription recombinase polymerase amplification assay for the detection of Middle East respiratory syndrome coronavirus. PLoS Curr 5: ecurrents.outbreaks.62df1c7c75ffc96cd59034531e2e8364. http://dx.doi.org/10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364.
8. Reusken CB, Haagmans BL, Muller MA, Gutierrez C, Godeke GJ, Meyer B, Muth D, Raj VS, Smits-De Vries L, Corman VM, Drexler J-F, Smits SL, El Tahir YE, De Sousa R, van Beek J, Nowotny N, van Maanen K, Hidalgo-Hermoso E, Bosch B-J, Rottier P, Osterhaus A, Gortazar-Schmidt C, Drosten C, Koopmans MPG. 2013. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13:859-866 http://dx.doi.org/10.1016/S1473-3099(13)70164-6.
9. Reusken C, Mou H, Godeke GJ, van der Hoek L, Meyer B, Muller MA, Haagmans B, de Sousa R, Schuurman N, Dittmer U, Rottier P, Osterhaus A, Drosten C, Bosch BJ, Koopmans M. 2013. Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill 18:pii=20441. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20441.
10. Meyer B, Müller MA, Corman VM, Reusken CBEM, Ritz D, Godeke GJ, Lattwein E, Kallies S, Siemens A, van Beek J, Drexler JF, Muth D, Bosch B-J, Wernery U, Koopmans MPG, Wernery R, Drosten C. 2003. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis 20:552-559. http://dx.doi.org/10.3201/eid2004.131746.
11. Buchholz U, Muller MA, Nitsche A, Sanewski A, Wevering N, Bauer-Balci T, Bonin F, Drosten C, Schweiger B, Wolff T, Muth D, Meyer B, Buda S, Krause G, Schaade L, Haas W. 2013. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill 18:pii=20406. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20406.
12. Annan A, Baldwin HJ, Corman VM, Klose SM, Owusu M, Nkrumah EE, Badu EK, Anti P, Agbenyega O, Meyer B, Oppong S, Sarkodie YA, Kalko EK, Lina PH, Godlevska EV, Reusken C, Seebens A, Gloza-Rausch F, Vallo P, Tschapka M, Drosten C, Drexler JF. 2013. Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis 19:456-459. http://dx.doi.org/10.3201/eid1903.121503.
13. Alexandersen S1, Kobinger GP, Soule G, Wernery U. 2014. Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005. Transbound Emerg Dis 61:105-108. http://dx.doi.org/10.1111/tbed.12212.
14. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, Siu LY, Shehata MM, Kayed AS, Moatasim Y, Li M, Poon LL, Guan Y, Webby RJ, Ali MA, Peiris JS, Kayali G 2013. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt. Euro Surveill 18:pii=20574. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20574.
15. st ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
16. Jacobson RH. 1998. Validation of serological assays for diagnosis of infectious diseases. Rev Sci Tech. 17:469-486.
17. Li XS, Fu F, Lang YK, Li HZ, Wang W, Chen X, Tian HB, Zhou YJ, Tong GZ, Li X. 2011. Development and preliminary application of an immunochromatographic strip for rapid detection of infection with porcine reproductive and respiratory syndrome virus in swine. J Virol Methods 176:46-52. http://dx.doi.org/10.1016/j.jviromet.2011.05.034.
18. Zhou SH, Cui SJ, Chen CM, Zhang FC, Li J, Zhou S, Oh JS. 2009. Development and validation of an immunogold chromatographic test for on-farm detection of PRRSV. J Virol Methods 160:178-184. http://dx.doi.org/10.1016/j.jviromet.2009.04.034.
19. OIE.2013. Principles and methods of validation of diagnostic assays for infectious diseases. World Organisation for Animal Health (OIE), Paris, France. http://www.oie.int/fileadmin/Home/fr/Health-standards/tahm/1.01.05-VALIDATION.pdf.